Karyopharm Therapeutics Inc (KPTI)
1.06
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.05
-0.01
(-0.94%)
After-Hours: 20:00
Karyopharm Therapeutics 1 Year Total Returns (Daily): -70.47% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | -70.47% |
April 25, 2024 | -71.73% |
April 24, 2024 | -73.35% |
April 23, 2024 | -73.35% |
April 22, 2024 | -72.37% |
April 19, 2024 | -71.74% |
April 18, 2024 | -69.16% |
April 17, 2024 | -69.93% |
April 16, 2024 | -74.54% |
April 15, 2024 | -73.26% |
April 12, 2024 | -68.06% |
April 11, 2024 | -67.79% |
April 10, 2024 | -67.35% |
April 09, 2024 | -67.32% |
April 08, 2024 | -67.07% |
April 05, 2024 | -65.22% |
April 04, 2024 | -66.16% |
April 03, 2024 | -67.63% |
April 02, 2024 | -64.14% |
April 01, 2024 | -59.38% |
March 28, 2024 | -56.98% |
March 27, 2024 | -57.59% |
March 26, 2024 | -58.13% |
March 25, 2024 | -58.13% |
March 22, 2024 | -57.10% |
Date | Value |
---|---|
March 21, 2024 | -59.20% |
March 20, 2024 | -60.34% |
March 19, 2024 | -59.71% |
March 18, 2024 | -56.76% |
March 15, 2024 | -56.61% |
March 14, 2024 | -61.93% |
March 13, 2024 | -59.08% |
March 12, 2024 | -51.67% |
March 11, 2024 | -50.67% |
March 08, 2024 | -49.52% |
March 07, 2024 | -51.43% |
March 06, 2024 | -58.44% |
March 05, 2024 | -60.22% |
March 04, 2024 | -58.15% |
March 01, 2024 | -61.65% |
February 29, 2024 | -61.59% |
February 28, 2024 | -55.96% |
February 27, 2024 | -53.62% |
February 26, 2024 | -56.33% |
February 23, 2024 | -61.01% |
February 22, 2024 | -64.47% |
February 21, 2024 | -62.19% |
February 20, 2024 | -65.92% |
February 16, 2024 | -64.62% |
February 15, 2024 | -64.48% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.65%
Minimum
Nov 10 2023
563.2%
Maximum
Mar 02 2020
-8.23%
Average
-47.53%
Median
Nov 04 2021
1 Year Total Returns (Daily) Benchmarks
Geron Corp | 55.97% |
Arbutus Biopharma Corp | 7.91% |
Verastem Inc | 109.1% |
Actinium Pharmaceuticals Inc | -21.93% |
Chimerix Inc | -21.41% |